Search tips
Search criteria 


Logo of thoraxThoraxVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Thorax. 2000 December; 55(12): 987–999.
PMCID: PMC1745657

Smoking cessation guidelines for health professionals: an update


This paper updates the evidence base and key recommendations of the Health Education Authority (HEA) smoking cessation guidelines for health professionals published in Thorax in 1998. The strategy for updating the evidence base makes use of updated Cochrane reviews supplemented by individual studies where appropriate. This update contains additional detail concerning the effectiveness of interventions as well as comments on issues relating to implementation. The recommendations include clarification of some important issues addressed only in general terms in the original guidelines. The conclusion that smoking cessation interventions delivered through the National Health Service are an extremely cost effective way of preserving life and reducing ill health remains unchanged. The strategy recommended by the guidelines involves: (1) GPs opportunistically advising smokers to stop during routine consultations, giving advice on and/or prescribing effective medications to help them and referring them to specialist cessation services; (2) specialist smokers' services providing behavioural support (in groups or individually) for smokers who want help with stopping and using effective medications wherever possible; (3) specialist cessation counsellors providing behavioural support for hospital patients and pregnant smokers who want help with stopping; (4) all health professionals involved in smoking cessation encouraging and assisting smokers in use of nicotine replacement therapies (NRT) or bupropion where appropriate. The key points of clarification of the previous guidelines include: (1) primary health care teams and hospitals should create and maintain readily accessible records on the current smoking status of patients; (2) GPs should aim to advise smokers to stop, and record having done so, at least once a year; (3) inpatient, outpatient, and pregnant smokers should be advised to stop as early as possible and the advice recorded in the notes in a readily accessible form; (4) there is currently little scientific basis for matching individual smokers to particular forms of NRT; (5) NHS specialist smokers' clinics should be the first point of referral for smokers wanting help beyond what can be provided through brief advice from the GP; (6) help from trained health care professionals specialising in smoking cessation such as practice nurses should be available for smokers who do not have access to specialist clinics; (7) the provision of specialist NHS smokers' clinics should be commensurate with demand; this is currently one or two full time clinics or their equivalent per average sized health authority, but demand may rise as publicity surrounding the services increases.

Full Text

The Full Text of this article is available as a PDF (172K).

Supplementary Material


Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax. 1998 Dec;53 (Suppl 5 Pt 1):S1–19. [PMC free article] [PubMed]
  • Parrott S, Godfrey C, Raw M, West R, McNeill A. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax. 1998 Dec;53 (Suppl 5 Pt 2):S1–38. [PMC free article] [PubMed]
  • Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J. 1979 Jul 28;2(6184):231–235. [PMC free article] [PubMed]
  • Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a priming effect. Arch Fam Med. 2000 May;9(5):426–433. [PubMed]
  • Richman PB, Dinowitz S, Nashed AH, Eskin B, Sylvan E, Allegra C, Allegra J, Mandell M. The emergency department as a potential site for smoking cessation intervention: a randomized, controlled trial. Acad Emerg Med. 2000 Apr;7(4):348–353. [PubMed]
  • Senore C, Battista RN, Shapiro SH, Segnan N, Ponti A, Rosso S, Aimar D. Predictors of smoking cessation following physicians' counseling. Prev Med. 1998 May-Jun;27(3):412–421. [PubMed]
  • Coleman T, Murphy E, Cheater F. Factors influencing discussion of smoking between general practitioners and patients who smoke: a qualitative study. Br J Gen Pract. 2000 Mar;50(452):207–210. [PMC free article] [PubMed]
  • Coleman T, Wilson A. Factors associated with the provision of anti-smoking advice by general practitioners. Br J Gen Pract. 1999 Jul;49(444):557–558. [PMC free article] [PubMed]
  • Butler CC, Pill R, Stott NC. Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion. BMJ. 1998 Jun 20;316(7148):1878–1881. [PMC free article] [PubMed]
  • Stott NC, Pill RM. Health promotion and the human response to loss: clinical implications of a decade of primary health care research. Fam Pract. 1987 Dec;4(4):278–286. [PubMed]
  • Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Jr, Enright PL, Kanner RE, O'Hara P, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–1505. [PubMed]
  • Steptoe A, Doherty S, Rink E, Kerry S, Kendrick T, Hilton S. Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. BMJ. 1999 Oct 9;319(7215):943–948. [PMC free article] [PubMed]
  • Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control. 1998 Autumn;7(3):253–261. [PMC free article] [PubMed]
  • Moolchan ET, Ernst M, Henningfield JE. A review of tobacco smoking in adolescents: treatment implications. J Am Acad Child Adolesc Psychiatry. 2000 Jun;39(6):682–693. [PubMed]
  • Melvin CL, Dolan-Mullen P, Windsor RA, Whiteside HP, Jr, Goldenberg RL. Recommended cessation counselling for pregnant women who smoke: a review of the evidence. Tob Control. 2000;9 (Suppl 3):III80–III84. [PMC free article] [PubMed]
  • Wisborg K, Henriksen TB, Secher NJ. A prospective intervention study of stopping smoking in pregnancy in a routine antenatal care setting. Br J Obstet Gynaecol. 1998 Nov;105(11):1171–1176. [PubMed]
  • Ussher MH, Taylor AH, West R, McEwen A. Does exercise aid smoking cessation? A systematic review. Addiction. 2000 Feb;95(2):199–208. [PubMed]
  • Turner RG, Pagoin JC, Martinez V, Coates A, Berg J. Promoting smoking cessation in general practice. BMJ. 1993 Oct 9;307(6909):939–939. [PMC free article] [PubMed]
  • Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med. 1999 Sep 27;159(17):2033–2038. [PubMed]
  • Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, et al. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med. 1999 Feb;28(2):113–118. [PubMed]
  • Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, Nides MA, Davidson M. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health. 1999 Nov;89(11):1701–1707. [PubMed]
  • Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med. 1998 Nov-Dec;7(6):569–574. [PubMed]
  • Shiffman S, Gitchell J, Pinney JM, Burton SL, Kemper KE, Lara EA. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997 Winter;6(4):306–310. [PMC free article] [PubMed]
  • Stapleton J. Commentary: Progress on nicotine replacement therapy for smokers. BMJ. 1999 Jan 30;318(7179):289–289. [PubMed]
  • Campbell IA, Prescott RJ, Tjeder-Burton SM. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med. 1996 Jan;90(1):47–51. [PubMed]
  • Lewis SF, Piasecki TM, Fiore MC, Anderson JE, Baker TB. Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med. 1998 Mar-Apr;27(2):296–303. [PubMed]
  • Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997 Jun;29(7):1422–1431. [PubMed]
  • Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996 Apr;20(2):115–126. [PubMed]
  • Lindblad A, Marsál K, Andersson KE. Effect of nicotine on human fetal blood flow. Obstet Gynecol. 1988 Sep;72(3 Pt 1):371–382. [PubMed]
  • Krishnamurthy S, Joshi S. Gender differences and low birth weight with maternal smokeless tobacco use in pregnancy. J Trop Pediatr. 1993 Aug;39(4):253–254. [PubMed]
  • Cummings KM, Hyland A, Ockene JK, Hymowitz N, Manley M. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. Tob Control. 1997;6 (Suppl 2):S63–S70. [PMC free article] [PubMed]
  • Shaw JP, Ferry DG, Pethica D, Brenner D, Tucker IG. Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies. Tob Control. 1998 Summer;7(2):161–167. [PMC free article] [PubMed]
  • Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997 Oct 23;337(17):1195–1202. [PubMed]
  • Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685–691. [PubMed]
  • Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ, Boles SM. Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res. 1996 Jun;11(2):243–257. [PubMed]
  • Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce JP. Telephone counseling for smoking cessation: effects of single-session and multiple-session interventions. J Consult Clin Psychol. 1996 Feb;64(1):202–211. [PubMed]
  • Owen L. Impact of a telephone helpline for smokers who called during a mass media campaign. Tob Control. 2000 Jun;9(2):148–154. [PMC free article] [PubMed]
  • Hajek P, Belcher M, Stapleton J. Enhancing the impact of groups: an evaluation of two group formats for smokers. Br J Clin Psychol. 1985 Nov;24(Pt 4):289–294. [PubMed]
  • Hajek P. Withdrawal-oriented therapy for smokers. Br J Addict. 1989 Jun;84(6):591–598. [PubMed]
  • Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Wiseman D. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction. 1995 Jan;90(1):31–42. [PubMed]
  • Stapleton JA, Lowin A, Russell MA. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet. 1999 Jul 17;354(9174):210–215. [PubMed]

Articles from Thorax are provided here courtesy of BMJ Publishing Group